3613 Stock Overview
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Beijing Tong Ren Tang Chinese Medicine Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$8.06 |
| 52 Week High | HK$13.44 |
| 52 Week Low | HK$7.03 |
| Beta | 0.47 |
| 11 Month Change | -3.70% |
| 3 Month Change | -7.89% |
| 1 Year Change | -35.00% |
| 33 Year Change | -19.32% |
| 5 Year Change | -20.20% |
| Change since IPO | -48.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3613 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -2.7% | -2.0% | -2.7% |
| 1Y | -35.0% | -9.4% | 10.9% |
Return vs Industry: 3613 underperformed the Hong Kong Pharmaceuticals industry which returned -8.3% over the past year.
Return vs Market: 3613 underperformed the Hong Kong Market which returned 11.3% over the past year.
Price Volatility
| 3613 volatility | |
|---|---|
| 3613 Average Weekly Movement | 6.7% |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 3613 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 3613's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1669 | 779 | Wang Chi | www.tongrentangcm.com |
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services.
Beijing Tong Ren Tang Chinese Medicine Company Limited Fundamentals Summary
| 3613 fundamental statistics | |
|---|---|
| Market cap | HK$6.75b |
| Earnings (TTM) | HK$494.14m |
| Revenue (TTM) | HK$1.38b |
13.7x
P/E Ratio4.9x
P/S RatioIs 3613 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3613 income statement (TTM) | |
|---|---|
| Revenue | HK$1.38b |
| Cost of Revenue | HK$384.69m |
| Gross Profit | HK$991.96m |
| Other Expenses | HK$497.83m |
| Earnings | HK$494.14m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.59 |
| Gross Margin | 72.06% |
| Net Profit Margin | 35.89% |
| Debt/Equity Ratio | 0.006% |
How did 3613 perform over the long term?
See historical performance and comparison